Filing Flows › Technology › GoodRx Holdings (GDRX)

GoodRx Holdings (GDRX) earnings and revenue breakdown

Latest: Q2 2026 · 10-Q filed Aug 5, 2026 · GoodRx Holdings (GDRX) Q2 2026 earnings results →

Q2 2026 Revenue down 1% year over year to $200M · 4¢ of every $1 of revenue kept as net profit · operating margin 11.8%

GoodRx Holdings made $200M in Q2 2026 (-1% Y/Y): Prescription transactions revenue $106M, Pharma Direct revenue $61.6M, Subscription revenue $28.5M. Operating margin 11.8%, net earnings $8.5M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 5, 2026.

Revenue$200M

Year over year-1%

Operating margin11.8%

Net earnings$8.5M

Operating cash flow$80.8M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $200.4M in Q2 2026, down 1% year over year and up 3% from the previous quarter. Prescription transactions revenue was the largest line at 53% of revenue. Prescription transactions revenue lost $36.7M year over year (down 26%), 1379% of the total change.

Operating profit was $23.6M, a 11.8% margin (down 1.4 points year over year). Total costs grew 0% against a revenue fall of 1%. The fastest-growing cost line was Cost of revenue (+57%). Net earnings were $8.5M, down 34% year over year. The effective tax rate was 44.8%.

Operating cash flow was $80.8M (up 63% year over year), 947% of net earnings. Non-cash charges added back $22.3M of depreciation and amortization and $16.6M of share-based compensation. Working capital and other items added $33.4M. Capital expenditures of $362K left free cash flow of $80.5M.

Quarterly history

Quarter	Form	Filed	Revenue	Y/Y	Op. margin	Net earnings	Op. cash flow
Q2 2026	10-Q	Aug 5, 2026	$200M	-1%	11.8%	$8.5M	$80.8M
Q1 2026	10-Q	May 6, 2026	$194M	-4%	7.2%	$1.2M	$11.8M
Q4 2025	10-K	Feb 26, 2026	$195M	-2%	11.6%	$5.4M	$32.9M
Q3 2025	10-Q	Nov 4, 2025	$196M	+0.4%	7.5%	$1.1M	$76.0M
Q2 2025	10-Q	Aug 6, 2025	$203M	+1%	13.2%	$12.8M	$49.6M
Q1 2025	10-Q	May 7, 2025	$203M	+3%	11.5%	$11.1M	$9.4M
Q4 2024	10-K	Feb 27, 2025	$199M	+1%	9.2%	$6.7M	$44.7M

Charts

Latest (Q2 2026): Y/Y -1%, Q/Q +3%.

From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.

Latest (Q2 2026): Net income $8.5M, Operating cash flow $80.8M.

+30.0% since FY2020: more shares outstanding (issuance, stock pay).

Cash $262M, short-term investments —, long-term debt $495M at 2025-12-31.

Services-Computer Processing & Data Preparation; dot size is quarterly revenue; dashed lines are the industry's medians.